# RPCRC Validation Study

> **NCT04484103** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 275 (actual)

## Conditions studied

- Multivariate Risk Assessment for ISUP ≥2 Prostate Cancer

## Interventions

- **OTHER:** Assessment of the diagnostic performance of the PI-RADS score (as a stand-alone) and of the RPCRC for predicting the presence of ISUP ≥2 prostate cancer at subsequent biopsy in 251 patients.

## Key facts

- **NCT ID:** NCT04484103
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484103, "RPCRC Validation Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04484103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*